VITROS CHEMISTRY PRODUCTS THEO SLIDES 1307164

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-03-04 for VITROS CHEMISTRY PRODUCTS THEO SLIDES 1307164 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[39988114] The investigation determined that lower than expected theophylline results were obtained from a non-vitros linearity fluid using vitros theo reagent with a vitros 5600 integrated system. A definitive assignable cause could not be determined. Vitros theo precision testing was not performed to verify instrument performance at the time of the events, therefore unexpected instrument performance cannot be ruled out as contributing to the event. The recommended handling protocols and stability characteristics of the non-vitros linearity fluids are not known, therefore inappropriate pre-analytical sample handling cannot be ruled out as a contributing factor. A review of historical quality control data showed atypical within-lab precision leading up to the events and on the day of the events, one level of quality control was outside of the customer? S established range. This indicates that the vitros theo reagent lot 2448-0088-6607 was not performing as expected when the lower than expected results were obtained. The lower than expected results were obtained after the customer performed a x5 dilution of the non-vitros linearity fluid. However an appropriate vitros theo result was previously obtained using a x2 dilution of the linearity fluid, which correlated with the result obtained from testing of the neat fluid. Good laboratory practice when the initial value is greater than the reportable range of the assay is to use values obtained using a minimal dilution factor. It is not known why the customer further diluted the non-vitros linearity fluid, or why this value was reported.
Patient Sequence No: 1, Text Type: N, H10


[39988115] A customer obtained lower than expected theophylline results (34. 1 ug/ml and 33. 9 ug/ml vs. Expected result of 48. 05 ug/ml) from a non-vitros linearity fluid, using vitros theo reagent with a vitros 5600 integrated system. Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples. The higher than expected theophylline results were generated from non-patient fluids and there is no allegation of patient harm as a result of the event. This report is number two of two mdrs for this event. Two 3500a forms are being submitted for this event as two devices were involved. This report corresponds to ortho clinical diagnostics inc. (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319809-2016-00031
MDR Report Key5479632
Date Received2016-03-04
Date of Report2016-03-04
Date of Event2015-11-20
Date Mfgr Received2016-02-08
Device Manufacturer Date2015-09-02
Date Added to Maude2016-03-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street513 TECHNOLOGY BLVD.
Manufacturer CityROCHESTER NY 14652
Manufacturer CountryUS
Manufacturer Postal Code14652
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS THEO SLIDES
Generic NameIN-VITRO DIAGNOSTIC
Product CodeKLS
Date Received2016-03-04
Catalog Number1307164
Lot Number2448-0088-6607
Device Expiration Date2017-03-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2016-03-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.